ABSTRACT
Objectives Recent studies suggested obesity to be a possible risk factor for COVID-19 disease in the wake of the coronavirus (SARS-CoV-2) infection. However, the causality and especially the role of body fat distribution in this context is still unclear. Thus, using a univariable as well as multivariable two-sample Mendelian randomization (MR) approach, we investigated for the first time the causal impact of body composition on the susceptibility and severity of COVID-19.
Methods As indicators of overall and abdominal obesity we considered the measures body mass index (BMI), waist circumference (WC), and trunk fat ratio (TFR). Summary statistics of genome-wide association studies (GWASs) for these body composition measures were drawn from the GIANT consortium and UK Biobank, while for susceptibility and severity due to COVID-19 disease data from the COVID-19 Host Genetics Initiative was used. For the COVID-19 cohort neither age nor gender was available. Total and direct causal effect estimates were calculated using Single Nucleotide Polymorphisms (SNPs), sensitivity analyses were done applying several robust MR techniques and mediation effects of type 2 diabetes (T2D) and cardiovascular diseases (CVD) were investigated within multivariable MR analyses.
Results Genetically predicted BMI was strongly associated with both, susceptibility (OR=1.31 per 1 SD increase; 95% CI: 1.15–1.50; P-value=7.3·10−5) and hospitalization (OR=1.62 per 1 SD increase; 95% CI: 1.33–1.99; P-value=2.8·10−6) even after adjustment for genetically predicted visceral obesity traits. These associations were neither mediated substantially by T2D nor by CVD. Finally, total but not direct effects of visceral body fat on outcomes could be detected.
Conclusions This study provides strong evidence for a causal impact of overall obesity on the susceptibility and severity of COVID-19 disease. The impact of abdominal obesity was weaker and disappeared after adjustment for BMI. Therefore, obese people should be regarded as a high-risk group. Future research is necessary to investigate the underlying mechanisms linking obesity with COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors did not receive funding for this study. Funding information of the genome-wide association studies is specified in the cited studies.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
In all original studies, ethical approval had been obtained.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declaration of interest: none
Revision based on reviewer comments
Data Availability
The present study is based on summary-level data that have been made publically available. Summary data from genome-wide association studies for the BMI (Pulit et al.) is available at https://zenodo.org/record/1251813#.XxgQ2J5KiUl, for WC (Shungin et al.) and BMI categories (Berndt et al.) at https://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files. Data for TFR (Rask-Andersen et al.) can be obtained from https://myfiles.uu.se/ssf/s/readFile/share/3993/1270878243748486898/publicLink/GWAS_summary_stats_ratios.zip[20]. The COVID-19 GWAS summary data are available at https://www.covid19hg.org/results. Summary level data for T2D can be obtained from MRC IEU OpenGWAS Project database (https://gwas.mrcieu.ac.uk/datasets/finn-a-E4_DM2/) and for CVD from http://www.cardiogramplusc4d.org/data-downloads/. In all original studies, ethical approval had been obtained.
https://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files
https://www.covid19hg.org/results
https://gwas.mrcieu.ac.uk/datasets/finn-a-E4_DM2/
